search
Back to results

Efficacy of Different Treatments for the Intensive Care Unit Acquired Weakness

Primary Purpose

Muscle Weakness, Rehabilitation

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
neuro muscular electro stimulation
Early Mobilization protocol
standard care or usual rehabilitation
Sponsored by
Hospital Nacional Profesor Alejandro Posadas
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Muscle Weakness focused on measuring Intensive Care Unit Acquired Weakness, Electric Stimulation Therapy, Early Mobility, Standard Rehabilitation Treatment

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • subjects over 18 years of age,
  • admitted to the ICU who have received invasive mechanical ventilation for a period longer than 24 hours
  • clinical diagnosis of ICUAW (MRC-mss <48 measured over two consecutive days).

Exclusion Criteria:

  • subjects who presented a body mass index> 35 (kg/height x height)
  • presence of edema that prevents the realization of NMES at the time of diagnosis of ICUAW (assessed by the absence of visible contraction
  • pregnant women
  • subjects with pacemakers
  • subjects with injury of the central and / or peripheral nervous system (with motor sequelae)
  • previous neuromuscular disease
  • limitation of the movement of any extremity due to orthopedic or traumatological causes
  • presence of a previous cognitive disorder that impedes the understanding of rehabilitation interventions
  • a value of the index of Barthel less than 35 points at admission
  • subjets who refused to give informed consent.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Active Comparator

    Experimental

    Experimental

    Arm Label

    standard care or usual rehabilitation

    neuro muscular electro stimulation

    early mobilization protocol

    Arm Description

    It will consist of the usual treatment performed by the intensive care physiotherapist, it will be applied every day that the study lasts.

    They received 5 sessions per week (except weekends) of neuromuscular electrostimulation of 30 minutes duration. Also, every day that the study is carried out in the morning and in the afternoon, the subjects will receive the usual treatment performed by the intensive care physiotherapist.

    Throughout the duration of the study, an early mobilization protocol will be applied to apply a specific treatment based on different levels of treatment for each subject of the group; It differs from the usual procedure in protocolized progression according to the objectives reached by the patient, unlike the usual treatment, where the progression is in accordance with the clinical criteria of the treatment professional.

    Outcomes

    Primary Outcome Measures

    days needs to revert ICUAW
    Number of days until reaching a value of the MRC-mss ≥ 48 points.
    Sessions needs to revert ICUAW
    Number of sessions until reaching a value of the MRC-mss ≥ 48 points.

    Secondary Outcome Measures

    Full Information

    First Posted
    June 21, 2018
    Last Updated
    October 31, 2020
    Sponsor
    Hospital Nacional Profesor Alejandro Posadas
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04613908
    Brief Title
    Efficacy of Different Treatments for the Intensive Care Unit Acquired Weakness
    Official Title
    Efficacy of Conventional Rehabilitation, Transcutaneous Electro Nerve Stimulation or Early Mobilization to Reverse the Acquired Weakness of the Intensive Care Unit: Single Blind Controlled Clinical Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2020
    Overall Recruitment Status
    Completed
    Study Start Date
    August 1, 2015 (Actual)
    Primary Completion Date
    August 31, 2016 (Actual)
    Study Completion Date
    August 31, 2016 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Hospital Nacional Profesor Alejandro Posadas

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Experimental study that has how to compare the efficacy between conventional rehabilitation, transcutaneous electrostimulation or early mobilization to reduce the time needed to reverse the muscle weakness evaluated by the muscle strength scale of the MRC in patients with a clinical diagnosis of intensive care unit acquired weakness in the (ICUAW).The ambit of realization is a medical-surgical ICU of a general acute hospital (26 beds). A randomized controlled, uni-centric design was used. The interventions are divided into three groups namely; group 1 (control group) receiving standard or usual rehabilitation (GR-STD); group 2 receives transcutaneous electrostimulation (GR-TEE) and group 3 that consists of an early mobilization protocol (GR-EM). The main outcome variable of the study is the time, in days and sessions of treatment, to reverse the ICUAW.
    Detailed Description
    Study hypothesis: the time to revert the intensive care unit acquired weakness is less when applying an early mobilization protocol or transcutaneous electro-nervous stimulation compared with the usual or standard rehabilitative treatment. Ethical considerations: The research protocol was presented and approved by both the Ethics Committee and the Teaching and Research Committee of our institution. The informed consent of each subject included in the study was obtained. Sample size and study power: a sample size was defined in 18 subjects (6 subjects per intervention group). The estimation of the sample was calculated for a one-way ANOVA where a minimum difference of 2 sessions was established between the treatments, assuming a standard deviation of 1.8 sessions, an alpha error of 5% and a power of 80%. Statistical methods: the numerical variables will be presented as mean and standard deviation or median and interquartile range according to the presented distribution. The categorical variables will be presented by frequency and percentage. For the comparison of continuous variables, Student's t test for independent samples or the Mann-Whitney U test will be used according to the presented distribution and for the categorical variables the Chi² test or the Fisher exact test will be used according to the conformation of the crossed table. The Shapiro-Wilk test will be used to evaluate whether the distribution presented by the numerical variables fits a normal distribution. Equality of variances was assessed by the Levene´s test. The comparison of the time to reach an smuscle strength scale of the MRC ≥ 48 between the groups with different interventions will be used the one-way ANOVA test or the Kruskal-Wallis test as appropriate. For post hoc analysis, the pairs-comparison test of Games-Hollew or Dunn's-Bonferroni will be used for ANOVA or Kruskal-Wallis, respectively, when they reach statistical significance.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Muscle Weakness, Rehabilitation
    Keywords
    Intensive Care Unit Acquired Weakness, Electric Stimulation Therapy, Early Mobility, Standard Rehabilitation Treatment

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    3 Groups Group 1 (GR-STD) received the standard or usual rehabilitation treatment used in our ICU as intervention. Group 2 (GR-NMES) received neuro muscular electro stimulation sessions in addition to the standard treatment. Group 3 (GR-EM) received an early mobilization protocol as intervention.
    Masking
    Outcomes Assessor
    Masking Description
    the person in charge of performing the statistical analysis was blind, by coding the interventions in the database.
    Allocation
    Randomized
    Enrollment
    18 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    standard care or usual rehabilitation
    Arm Type
    Active Comparator
    Arm Description
    It will consist of the usual treatment performed by the intensive care physiotherapist, it will be applied every day that the study lasts.
    Arm Title
    neuro muscular electro stimulation
    Arm Type
    Experimental
    Arm Description
    They received 5 sessions per week (except weekends) of neuromuscular electrostimulation of 30 minutes duration. Also, every day that the study is carried out in the morning and in the afternoon, the subjects will receive the usual treatment performed by the intensive care physiotherapist.
    Arm Title
    early mobilization protocol
    Arm Type
    Experimental
    Arm Description
    Throughout the duration of the study, an early mobilization protocol will be applied to apply a specific treatment based on different levels of treatment for each subject of the group; It differs from the usual procedure in protocolized progression according to the objectives reached by the patient, unlike the usual treatment, where the progression is in accordance with the clinical criteria of the treatment professional.
    Intervention Type
    Device
    Intervention Name(s)
    neuro muscular electro stimulation
    Other Intervention Name(s)
    DEMAX® model Quatrum Duo
    Intervention Description
    We used a commercial equipment of electro stimulation with a pulse width of 300 micro seconds, a frequency of 50 Hz, with symmetrical balanced biphasic rectangular wave and with an intensity of up to 80 milliampere.
    Intervention Type
    Other
    Intervention Name(s)
    Early Mobilization protocol
    Intervention Description
    The protocol consisted in applying a specific treatment based on different levels of treatment to each subject. Admission to them was carried out according to the maximum capacity of each subject, the conditions of each level being the following: Level 1: MRC (shoulder) <3 + MRC <3 (hip). Level 2: MRC (shoulder) ≥ 3 + MRC (hip) <3. Level 3: MRC (shoulder) ≥ 3 + MRC (hip) ≥ 3 + sitting on the edge of the bed without assistance (minimum 15 minutes). Level 4: Standing without assistance and walking with or without assistance.
    Intervention Type
    Other
    Intervention Name(s)
    standard care or usual rehabilitation
    Intervention Description
    routine, non-protocolized rehabilitation treatment performed by the physiotherapist assigned to intensive care
    Primary Outcome Measure Information:
    Title
    days needs to revert ICUAW
    Description
    Number of days until reaching a value of the MRC-mss ≥ 48 points.
    Time Frame
    3 months
    Title
    Sessions needs to revert ICUAW
    Description
    Number of sessions until reaching a value of the MRC-mss ≥ 48 points.
    Time Frame
    3 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: subjects over 18 years of age, admitted to the ICU who have received invasive mechanical ventilation for a period longer than 24 hours clinical diagnosis of ICUAW (MRC-mss <48 measured over two consecutive days). Exclusion Criteria: subjects who presented a body mass index> 35 (kg/height x height) presence of edema that prevents the realization of NMES at the time of diagnosis of ICUAW (assessed by the absence of visible contraction pregnant women subjects with pacemakers subjects with injury of the central and / or peripheral nervous system (with motor sequelae) previous neuromuscular disease limitation of the movement of any extremity due to orthopedic or traumatological causes presence of a previous cognitive disorder that impedes the understanding of rehabilitation interventions a value of the index of Barthel less than 35 points at admission subjets who refused to give informed consent.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Ladislao P Diaz Ballve
    Organizational Affiliation
    Hospital Nacional Posadas
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Efficacy of Different Treatments for the Intensive Care Unit Acquired Weakness

    We'll reach out to this number within 24 hrs